Matrix metalloproteinases 2 and 9 in human atherosclerotic and non-atherosclerotic cerebral aneurysms

European Journal of Neurology

Volumn 13, Issue 10, 2006, Pages 1098-1105

  Caird, J ^a   Napoli, C ^b,c   Taggart, C ^a   Farrell, M ^d   Bouchier Hayes, D ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BEAUMONT HOSPITAL   (Ireland)

Author keywords

Atherosclerosis; Cerebral aneurysm; Matrix metalloproteinase

Indexed keywords

GELATINASE A; GELATINASE B; RECOMBINANT PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; ATHEROGENESIS; BRAIN ARTERY ANEURYSM; BRAIN ATHEROSCLEROSIS; BRAIN CIRCULUS ARTERIOSUS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRACRANIAL ANEURYSM; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK ASSESSMENT; SMOOTH MUSCLE FIBER; ZYMOGRAPHY;

ADOLESCENT; ADULT; AGED; ATHEROSCLEROSIS; CIRCLE OF WILLIS; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HUMANS; INTRACRANIAL ANEURYSM; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED;

EID: 33748950277     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2006.01469.x     Document Type: Article

References (33)

1. Pasterkamp G, Schoneveld A, Jan Hijnen D, et al. Atherosclerotic arterial remodelling and the localization of macrophages and matrix metalloproteinases 1, 2 and 9 in the human coronary artery. Atherosclerosis 2000; 150: 245-253.
2. Yong V, Power C, Forsyth P, Edwards D. Matrix metalloproteinases in biology and pathology of the nervous system. Nature Reviews Neuroscience 2001; 2: 502-511.
3. Montaner J, Alvarez-Sabin J, Molina C, et al. Matrix metalloproteinase expression after human cardioembolic stroke: temporal profile and relation to neurological impairment. Stroke 2001; 32: 1759-1766.
4. D'Armiento FP, Bianchi A, de Nigris F, et al. Age-related effects on atherogenesis and scavenger enzymes of intracranial and extracranial arteries in men without classical risk factors for atherosclerosis. Stroke 2001; 32: 2472-2480.
5. Napoli C, Palinski W. Neurodegenerative diseases: insights into pathogenic mechanisms from atherosclerosis. Neurobiology of Aging 2005; 26: 293-302.
6. Inci S, Spetzler R. Intracranial aneurysms and arterial hypertension: a review and hypothesis. Surgical Neurology 2000; 53: 530-542.
7. Stehbens W. Etiology of intracranial berry aneurysms. Review article. Journal of Neurosurgery 1989; 70: 823-831.
8. Kadoglou N, Liapis C. Matrixmetalloproteinases: contribution to pathogenesis, diagnosis, surveillance and treatment of abdominal aortic aneurysms. Current Medical Research and Opinion 2004; 20: 419-32.
9. Patel M, Melrose J, Ghosh P, et al. Increased synthesis of matrix metalloproteinases by aortic smooth muscle cells is implicated in the etiopathogenesis of abdominal aortic aneurysms. Journal of Vascular Surgery 1996; 24: 82-92.
10. Sinha S, Frishman W. Matrix metalloproteinases and abdominal aortic aneurysms: a potential therapeutic target. Journal of Clinical Pharmacology 1998; 38: 1077-1088.
11. Crowther M, Goodall S, Jones J, et al. Localization of matrix metalloproteinase 2 within the aneurysmal and normal aortic wall. British Journal of Surgery 2000; 87: 1391-1400.
12. Kim S, Singh M, Huang J, et al. Matrix metalloproteinase 9 in cerebral aneurysms. Neurosurgery 1997; 41: 642-647.
13. Chyatte D, Lewis I. Gelatinase activity and the occurrence of cerebral aneurysms. Stroke 1997; 28: 799-804.
14. Todor D, Lewis I, Bruno G, et al. Identification of a serum gelatinase associated with the occurrence of cerebral aneurysms as pro-matrix metalloproteinase 2. Stroke 1998; 29: 1580-1583.
15. Bruno G, Todor R, Lewis I, et al. Vascular extracellular matrix remodelling in cerebral aneurysms. Journal of Neurosurgery 1998; 89: 431-440.
16. Shaw MDM. Aneurysms. In: Miller JD, ed. Northfield's Surgery of the CNS. London: Blackwell Scientific Publications, 1987: 378-439
17. Caird J, Burke M, Roberts G, et al. Apolipoprotein (a) expression in intracranial aneurysms. Neurosurgery 2003; 52: 854-859.
18. Schievink W. Intracranial aneurysms. New England Journal of Medicine 1997; 336: 28-40.
19. Napoli C, Witztum J, de Nigris F, et al. Intracranial arteries of human fetuses are more resistant to hypercholesterolemia-induced fatty streak formation than extracranial arteries. Circulation 1999; 99: 2003-2010.
20. Scott R, Ashton H, Buxton M, et al. The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial. Lancet 2002; 360: 1531-1539.
21. Wiebers D, Whisnant J, Forbes G, et al. Unruptured intracranial aneurysms - risk of rupture and risks of surgical intervention. The International Study of Unruptured Intracranial Aneurysm investigators (ISUIA). The New England Journal of Medicine 1998; 339: 1725-1733.
22. Crowther M, Goodall S, Jones J, et al. Increased matrix metalloproteinase 2 expression in vascular smooth muscle cells cultured from abdominal aortic aneurysms. Journal of Vascular Surgery 2000; 32: 575-583.
23. Longo M, Xiong W, Greiner T, et al. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. Journal of Clinical Investigation 2002; 110: 625-632.
24. Saito S, Zempo N, Yamashita A, et al. Matrix metalloproteinase expressions in arteriosclerotic aneurysmal disease. Vascular and Endovascular Surgery 2002; 36: 1-7.
25. Lemaitre V, Soloway P, D'Armiento J. Increased medial degradation with pseudo-aneurysm formation in apolipoprotein E-knockout mice deficient in tissue inhibitor of metalloproteinases-1. Circulation 2003; 107: 333-338.
26. Allaire E, Forough R, Clowes M, et al. Local overexpression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model. Journal of Clinical Investigation 1998; 102: 1413-1420.
27. Krex D, Rohl H, Konig I, et al. Tissue inhibitor of metalloproteinases-1, -2, and -3 polymorphisms in a white population with intracranial aneurysms. Stroke 2003; 34: 2817-2821.
28. Jamieson D, Usher D, Rader D, et al. Apolipoprotein(a) deposition in atherosclerotic plaques of cerebral vessels. American Journal of Pathology 1995; 147: 1567-1574.
29. Sato H, Takino T, Kinoshita T, et al. Cell surface binding and activation of gelatinase A induced by expression of membrane-type-1-matrix metalloproteinase (MT1-MMP). FEBS Letters 1996; 385: 238-240.
30. McLean J, Tomlinson J, Khang W, et al. DNA sequence of human apolipoprotein (a) is homologous to plasminogen. Nature 1987; 30: 132-137.
31. Nachman R. Lipoprotein (a): molecular mischief in the microvasculature. Editorial. Circulation 1997; 96: 2485-2487.
32. Bendeck M, Conte M, Zhang M, et al. Doxycycline modulates smooth muscle cell growth, migration and matrix remodelling after arterial injury. American Journal of Pathology 2002; 160: 1089-1095.
33. Ribourtout E, Raymond J. Gene therapy and endovascular treatment of intracranial aneurysms. Stroke 2004; 35: 786-793.